• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

α-萘黄酮对人细胞色素P450 1A2的紧密结合抑制作用。

Tight-binding inhibition by alpha-naphthoflavone of human cytochrome P450 1A2.

作者信息

Cho Uhn Soo, Park Eun Young, Dong Mi Sook, Park Bum Seok, Kim Keehyuk, Kim Kyung Hyun

机构信息

Graduate School of Biotechnology, Korea University, 5-1 Anam dong, Sungbuk-gu, Seoul 136-701, South Korea.

出版信息

Biochim Biophys Acta. 2003 May 30;1648(1-2):195-202. doi: 10.1016/s1570-9639(03)00148-1.

DOI:10.1016/s1570-9639(03)00148-1
PMID:12758162
Abstract

Human cytochrome P450 (P450) enzymes exhibit remarkable diversity in their substrate specificities, participating in oxidation reactions of a wide range of xenobiotic drugs. Previously, we reported that alpha-naphthoflavone (ANF) is bound to the recombinant P450 1A2 tightly and stabilizes an overall enzyme conformation. The present study is designed to determine the type of P450 1A2 inhibition exerted by ANF, using two different substrates of P450 1A2, 7-ethoxycoumarin (EOC) and 7-ethoxyresorufin (EOR). ANF is generally known as a competitive inhibitor of the enzyme. However, in our tight-binding enzyme kinetics study, ANF acts as noncompetitive inhibitor in 7-ethoxycoumarin O-deethylation (ECOD) (K(i)=55.0 nM), but as competitive inhibitor in 7-ethoxyresorufin O-deethylation (EROD) (K(i)=1.4 nM). Based on homology modeling studies, ANF is positioned to bind to a hydrophobic cavity next to the active site where it may cause a direct effect on substrate binding. It is agreed with the predicted binding site of ANF in P450 3A4, in which ANF is rather known as a stimulating modulator. Our results suggest that ANF binds near the active site of P450 1A2 and exhibits differential inhibition mechanisms, possibly depending on the molecular structure of the substrate.

摘要

人类细胞色素P450(P450)酶在底物特异性方面表现出显著的多样性,参与多种外源性药物的氧化反应。此前,我们报道了α-萘黄酮(ANF)与重组P450 1A2紧密结合,并稳定了整个酶的构象。本研究旨在使用P450 1A2的两种不同底物7-乙氧基香豆素(EOC)和7-乙氧基试卤灵(EOR)来确定ANF对P450 1A2的抑制类型。ANF通常被认为是该酶的竞争性抑制剂。然而,在我们的紧密结合酶动力学研究中,ANF在7-乙氧基香豆素O-脱乙基化(ECOD)反应中表现为非竞争性抑制剂(K(i)=55.0 nM),但在7-乙氧基试卤灵O-脱乙基化(EROD)反应中表现为竞争性抑制剂(K(i)=1.4 nM)。基于同源建模研究,ANF位于活性位点旁边的疏水腔中,在那里它可能对底物结合产生直接影响。这与ANF在P450 3A4中的预测结合位点一致,在P450 3A4中,ANF更被认为是一种刺激调节剂。我们的结果表明,ANF结合在P450 1A2活性位点附近,并表现出不同的抑制机制,这可能取决于底物的分子结构。

相似文献

1
Tight-binding inhibition by alpha-naphthoflavone of human cytochrome P450 1A2.α-萘黄酮对人细胞色素P450 1A2的紧密结合抑制作用。
Biochim Biophys Acta. 2003 May 30;1648(1-2):195-202. doi: 10.1016/s1570-9639(03)00148-1.
2
Influence of ligand binding to human cytochrome P-450 1A2: conformational activation and stabilization by alpha-naphthoflavone.配体与人类细胞色素P-450 1A2结合的影响:α-萘黄酮的构象激活与稳定作用
Biochim Biophys Acta. 2001 Apr 7;1546(2):412-21. doi: 10.1016/s0167-4838(01)00165-0.
3
The molecular basis for the inhibition of human cytochrome P450 1A2 by oroxylin and wogonin.大黄素和甘草素抑制人细胞色素 P450 1A2 的分子基础。
Eur Biophys J. 2012 Mar;41(3):297-306. doi: 10.1007/s00249-011-0785-1. Epub 2012 Jan 8.
4
Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2.人细胞色素P450 1A2结构所展现出的对多环芳烃氧化的适应性。
J Biol Chem. 2007 May 11;282(19):14348-55. doi: 10.1074/jbc.M611692200. Epub 2007 Feb 20.
5
Inhibition of human CYP1 enzymes by a classical inhibitor α-naphthoflavone and a novel inhibitor N-(3, 5-dichlorophenyl)cyclopropanecarboxamide: An in vitro and in silico study.α-萘黄酮和新型抑制剂 N-(3,5-二氯苯基)环丙烷甲酰胺对人 CYP1 酶的抑制作用:体外和计算研究。
Chem Biol Drug Des. 2020 May;95(5):520-533. doi: 10.1111/cbdd.13669. Epub 2020 Mar 9.
6
Investigation of substrate recognition for cytochrome P450 1A2 mediated by water molecules using docking and molecular dynamics simulations.利用对接和分子动力学模拟研究水分子介导的细胞色素P450 1A2的底物识别
J Mol Graph Model. 2017 Jun;74:326-336. doi: 10.1016/j.jmgm.2017.04.006. Epub 2017 Apr 13.
7
Different mechanisms for inhibition of human cytochromes P450 1A1, 1A2, and 1B1 by polycyclic aromatic inhibitors.多环芳烃抑制剂对人细胞色素P450 1A1、1A2和1B1的不同抑制机制。
Chem Res Toxicol. 2007 Mar;20(3):489-96. doi: 10.1021/tx600299p. Epub 2007 Feb 10.
8
Molecular cloning and functional analysis of cytochrome P450 1A2 from Japanese monkey liver: comparison with marmoset cytochrome P450 1A2.日本猕猴肝脏细胞色素P450 1A2的分子克隆与功能分析:与狨猴细胞色素P450 1A2的比较
Chem Biol Interact. 2005 Feb 28;152(1):1-12. doi: 10.1016/j.cbi.2005.01.006.
9
Environmentally persistent free radical-containing particulate matter competitively inhibits metabolism by cytochrome P450 1A2.含有环境持久性自由基的颗粒物会竞争性抑制细胞色素P450 1A2的代谢。
Toxicol Appl Pharmacol. 2015 Dec 1;289(2):223-30. doi: 10.1016/j.taap.2015.09.021. Epub 2015 Sep 28.
10
Isoform-selective inhibition of chrysin towards human cytochrome P450 1A2. Kinetics analysis, molecular docking, and molecular dynamics simulations.染料木黄酮对人细胞色素 P4501A2 的同工酶选择性抑制。动力学分析、分子对接和分子动力学模拟。
Bioorg Med Chem Lett. 2010 Oct 15;20(20):6008-12. doi: 10.1016/j.bmcl.2010.08.072. Epub 2010 Aug 20.

引用本文的文献

1
In vitro assessment of the potential for dolutegravir to affect hepatic clearance of levonorgestrel.体外评估多拉韦林对左炔诺孕酮肝清除率的潜在影响。
HIV Med. 2021 Nov;22(10):898-906. doi: 10.1111/hiv.13136. Epub 2021 Jul 30.
2
Identifying cytochrome P450s involved in oxidative metabolism of synthetic cannabinoid N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide (STS-135).鉴定参与合成大麻素 N-(金刚烷-1-基)-1-(5-氟戊基)-1H-吲哚-3-甲酰胺(STS-135)氧化代谢的细胞色素 P450s。
Pharmacol Res Perspect. 2020 Feb;8(1):e00561. doi: 10.1002/prp2.561.
3
Sensitive CometChip assay for screening potentially carcinogenic DNA adducts by trapping DNA repair intermediates.
通过捕获 DNA 修复中间体筛选潜在致癌性 DNA 加合物的敏感彗星芯片分析。
Nucleic Acids Res. 2020 Feb 20;48(3):e13. doi: 10.1093/nar/gkz1077.
4
Microcolony Size Distribution Assay Enables High-Throughput Cell Survival Quantitation.微菌落大小分布分析可实现高通量细胞存活定量。
Cell Rep. 2019 Feb 5;26(6):1668-1678.e4. doi: 10.1016/j.celrep.2019.01.053.
5
Pharmacological inhibition of CaMKK2 with the selective antagonist STO-609 regresses NAFLD.选择性钙调蛋白依赖性激酶激酶 2(CaMKK2)抑制剂 STO-609 可逆转非酒精性脂肪性肝病(NAFLD)。
Sci Rep. 2017 Sep 18;7(1):11793. doi: 10.1038/s41598-017-12139-3.
6
Linear Interaction Energy Based Prediction of Cytochrome P450 1A2 Binding Affinities with Reliability Estimation.基于线性相互作用能的细胞色素P450 1A2结合亲和力预测及可靠性估计
PLoS One. 2015 Nov 9;10(11):e0142232. doi: 10.1371/journal.pone.0142232. eCollection 2015.
7
Carbon-carbon bond cleavage in activation of the prodrug nabumetone.前药萘丁美酮活化过程中的碳-碳键断裂
Drug Metab Dispos. 2014 May;42(5):828-38. doi: 10.1124/dmd.114.056903. Epub 2014 Feb 28.
8
The molecular basis for the inhibition of human cytochrome P450 1A2 by oroxylin and wogonin.大黄素和甘草素抑制人细胞色素 P450 1A2 的分子基础。
Eur Biophys J. 2012 Mar;41(3):297-306. doi: 10.1007/s00249-011-0785-1. Epub 2012 Jan 8.
9
Insights into the substrate specificity, inhibitors, regulation, and polymorphisms and the clinical impact of human cytochrome P450 1A2.对人类细胞色素P450 1A2的底物特异性、抑制剂、调节、多态性及其临床影响的见解。
AAPS J. 2009 Sep;11(3):481-94. doi: 10.1208/s12248-009-9127-y. Epub 2009 Jul 10.
10
Differential inhibition of cytochromes P450 3A4 and 3A5 by the newly synthesized coumarin derivatives 7-coumarin propargyl ether and 7-(4-trifluoromethyl)coumarin propargyl ether.新合成的香豆素衍生物7-香豆素炔丙基醚和7-(4-三氟甲基)香豆素炔丙基醚对细胞色素P450 3A4和3A5的差异抑制作用。
Drug Metab Dispos. 2008 Nov;36(11):2234-43. doi: 10.1124/dmd.108.021493. Epub 2008 Jul 24.